2021 SOCRA NYS Chapter Virtual Series: Asia Pacific and European (MDR & IVDR) Clinical Evaluation Reports and Latest Requirements for Post Market Reporting
12 March, 2021
Our VP of Business Development, Luis Jimenez will be presenting to the SOCRA NY Chapter on: Asia Pacific and European (MDR & IVDR) Clinical Evaluation Reports and Latest Requirements for Post Market Reporting.
As Europe transitions to the MDR/IVDR and Asia Pacific Regulators (including Australia’s TGA) focus more on clinical evidence, creating a Clinical Evaluation Report (CER) that meets international regulators’ expectations is becoming increasingly complex. Luis will review MEDDEV 2.7/1 Rev 4 requirements with an emphasis on strategies to meet individual requirements of specific regulators in one document. Key guidance’s on navigating the world of Clinical Evaluation Report and the MEDDEV 2.7/1 revision 4 guidance will be shared. This topic will also cover areas of focus for manufacturers and sponsors, based on recent feedback from European Notified Bodies and TGA reviews.
Share this event
Date and Time
12 March 2021
12:00 pm - 1:30 pm
USA / Canada EST